JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 21, 2005; DOI: 10.1124/jpet.105.096396


0022-3565/06/3171-61-67$20.00
JPET 317:61-67, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.096396v1
317/1/61    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karuri, A. R.
Right arrow Articles by Sutter, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karuri, A. R.
Right arrow Articles by Sutter, T. R.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

3H-1,2-Dithiole-3-thione Targets Nuclear Factor {kappa}B to Block Expression of Inducible Nitric-Oxide Synthase, Prevents Hypotension, and Improves Survival in Endotoxemic Rats

Asok R. Karuri, Yong Huang, Sridevi Bodreddigari, Carrie Hayes Sutter, Bill D. Roebuck, Thomas W. Kensler, and Thomas R. Sutter

W. Harry Feinstone Center for Genomic Research, University of Memphis, Memphis, Tennessee (A.R.K., Y.H., S.B., C.H.S., T.R.S.); Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire (B.D.R.); and Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (T.W.K.)

Septicemia is a major cause of death associated with noncoronary intensive care. Systemic production of nitric oxide (NO) by inducible nitric-oxide synthase (iNOS) is a major cause of hypotension and poor organ perfusion seen in septic shock. Here, we show that pretreatment of F344 rats with the cancer chemoprotective agent 3H-1,2-dithiole-3-thione (D3T) blocks lipopolysaccharide (LPS)-mediated induction of hepatic iNOS and significantly reduces the associated serum levels of NO metabolites and enzyme markers of toxicity provoked by treatment with LPS. Immunohistochemical analysis shows that this protective effect is largely due to suppression of iNOS expression in hepatocytes. Importantly, pretreatment of animals with D3T blunts LPS-mediated hypotension and dramatically increases their survival. Inasmuch as iNOS expression can be regulated by nuclear factor (NF) {kappa}B, mechanistic studies show that D3T blocks NF{kappa}B nuclear translocation and DNA binding and that these effects are accompanied by changes in the levels of phospho-inhibitor of NF{kappa}B. In conclusion, this study identifies new drug classes and targets that may improve the prevention and treatment of septic shock, as well as chronic diseases associated with the NF{kappa}B and iNOS pathways.


Received October 3, 2005; accepted December 20, 2005.

Address correspondence to: Thomas R. Sutter, W. Harry Feinstone Center for Genomic Research, 201 Life Science Building, University of Memphis, Memphis, TN 38152. E-mail: tsutter{at}memphis.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.